Truncated proteins as cancer markers
US7767789B2 · kind B2 · utility
26Cited by
14References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 2, 2006 |
| Grant date | Aug 3, 2010 |
| Priority date | — |
| Expiry date | Jun 2, 2026 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/57492
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Methods/reagents for detecting and/or treating cancers or potential cancers are disclosed. In one embodiment, methods and reagents for detecting truncated forms of P2X7 protein in cells are described. In one embodiment, methods and reagents for increasing the amount and/or activity of full-length P2X7 in cells are described. In one embodiment, methods and reagents for decreasing the amount and/or activity of truncated P2X7 in cells are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.